South Korean Feline Kidney Care Brand to Showcase Greycoat Dr. Toru and Greycoat AIM Bites in Las Vegas

 

Greycoat Research will introduce its “Cat Kidney Store” concept at SUPERZOO 2026, marking another important step in the company’s expansion across the North American market.

SUPERZOO 2026 will take place from August 12 to 14 at the Mandalay Bay Convention Center in Las Vegas.

Distributors, retailers, veterinarians, and industry partners will be able to meet the Greycoat Research team at Booth 9466.

According to company sales data, Greycoat Research’s U.S. sales increased 8.5-fold from 2024 to 2025 and continued to grow through June 2026.

The United States now represents approximately 67% of the company’s international sales, making it Greycoat Research’s largest overseas market.

At SUPERZOO, Greycoat Research will showcase Greycoat Dr. Toru, an AIM-based capsule supplement, and Greycoat AIM Bites, palatable low-protein treats developed for convenient daily feeding.

The company’s “Cat Kidney Store” concept brings together specialized nutritional supplements, low-protein treats, and practical nutrition guidance to make daily feline kidney care more accessible and manageable.

Greycoat Research’s product development is informed by Japanese AIM research.

AIM, short for apoptosis inhibitor of macrophage, is a protein studied in relation to kidney biology in cats.

The company’s expert team includes veterinarians, pharmacists, biology researchers, and veterinary nutrition experts.

Greycoat Research began with TT, the cat at the center of Claire Luvcat, a YouTube channel with approximately 1.3 million subscribers worldwide.

TT was diagnosed with Stage 2 chronic kidney disease eight years ago and has since received long-term nutritional management and consistent daily care.

Over the course of eight years, TT’s kidney-related values improved and have remained stable.

That experience became the foundation of Greycoat Research.

What began with one cat has grown into a global feline kidney care brand supporting more than 10,000 cats worldwide.

With South Korea and Japan as its core markets, Greycoat Research has sold more than 100,000 units across 33 countries.

The company has also conducted more than 5,000 consultations involving cats with chronic kidney disease.

“Our journey began with TT and one clear hope: to help more cats with kidney disease enjoy healthier and happier days,” said Claire Yun, CEO of Greycoat Research.

“Eight years later, that hope continues to guide everything we do. SUPERZOO represents our next step in bringing this mission to more cats and building trusted, long-term partnerships throughout North America.”

Greycoat Research plans to use SUPERZOO 2026 as an opportunity to strengthen relationships with distributors, retailers, veterinary professionals, and potential industry partners in the United States.

The exhibition also represents an important milestone in the company’s efforts to expand its international research, consultation, and distribution network centered on feline kidney health.

For partnership, distribution, research, or veterinary collaboration inquiries, please contact:
sales@greycoatresearch.com

[Disclaimer]

Greycoat Research develops nutritional supplements, treats, and care programs designed to support feline well-being and kidney health.

Its products are not intended to diagnose, treat, cure, or prevent any disease. Pet owners should consult a licensed veterinarian for medical advice.